Paris Riggle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Paris Riggle has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Bo Zhou
Human Genetics Department, University of Michigan Medical School, Ann Arbor, MI, 48109, USA
1 shared publicationGrace Lin
Pediatrics Department, Division of Pediatric Neurology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA
1 shared publication- Louis T. Dang
Department of Pediatrics, University of Michigan, Ann Arbor
1 shared publication Michael A. Sutton
Molecular & Integrative Physiology Department, Michigan Neuroscience Institute, University of Michigan Medical School, Ann Arbor, MI, 48109, USA
1 shared publication- Satabdi Mohanty
Human Genetics Department, University of Michigan Medical School, Ann Arbor, MI, 48109, USA
1 shared publication - Shigeki Iwase
Department of Human Genetics, University of Michigan Medical School, Ann Arbor, USA
1 shared publication
Latest Publications
- Open Access
RAI1 safeguards fidelity and tempo of human neurodevelopmental gene expression
Human brain development proceeds on an unusually long timeline relative to other species, a feature that is thought to foster advanced cognitive abilities. Retinoic Acid Induced 1 ( RAI1 ) gene encodes a nucleosome-binding protein haploinsufficient in Smith–Magenis Syndrome (SMS), a neurodevelopmental disorder characterized by cognitive impairment with autistic features. However, the role of RAI1 in human neurodevelopment remains unexplored experimentally. Here, we generated isogenic heterozygous and homozygous RAI1 loss-of-function human embryonic stem cell lines and interrogated the roles of RAI1 in neurodevelopmental gene regulation. A longitudinal transcriptome analysis during in vitro cortical development revealed that RAI1 deficiency accelerates developmental gene expression progression, including the precocious induction of synaptic genes. Single-cell RNA-seq analysis revealed that RAI1- deficient neuroprogenitors acquire a transient mesoderm-like gene expression signature followed by pro-neuronal maturation gene expression in postmitotic neurons. Unexpectedly, the developmental acceleration signature was exacerbated during NGN2-induced excitatory neuron differentiation, suggesting functional interplay between RAI1 and NGN2-driven programs. Together, these results identify RAI1 as a suppressor of the mesodermal lineage program and as a novel brake that slows the tempo of human neurodevelopmental gene expression.
Open AccessRAI1 safeguards fidelity and tempo of human neurodevelopmental gene expression
Human brain development proceeds on an unusually long timeline relative to other species, a feature that is thought to foster advanced cognitive abilities. Retinoic Acid Induced 1 ( RAI1 ) gene encodes a nucleosome-binding protein haploinsufficient in Smith–Magenis Syndrome (SMS), a neurodevelopmental disorder characterized by cognitive impairment with autistic features. However, the role of RAI1 in human neurodevelopment remains unexplored experimentally. Here, we generated isogenic heterozygous and homozygous RAI1 loss-of-function human embryonic stem cell lines and interrogated the roles of RAI1 in neurodevelopmental gene regulation. A longitudinal transcriptome analysis during in vitro cortical development revealed that RAI1 deficiency accelerates developmental gene expression progression, including the precocious induction of synaptic genes. Single-cell RNA-seq analysis revealed that RAI1- deficient neuroprogenitors acquire a transient mesoderm-like gene expression signature followed by pro-neuronal maturation gene expression in postmitotic neurons. Unexpectedly, the developmental acceleration signature was exacerbated during NGN2-induced excitatory neuron differentiation, suggesting functional interplay between RAI1 and NGN2-driven programs. Together, these results identify RAI1 as a suppressor of the mesodermal lineage program and as a novel brake that slows the tempo of human neurodevelopmental gene expression.